• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. FLUENCY PLUS ENDOVASCULAR STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. FLUENCY PLUS ENDOVASCULAR STENT GRAFT Back to Search Results
Catalog Number FEM14080
Device Problems Break (1069); Misfire (2532); Detachment of Device or Device Component (2907)
Patient Problem Embolism/Embolus (4438)
Event Date 08/21/2023
Event Type  Injury  
Manufacturer Narrative
H10: as the lot number for the device was provided, a review of the device history records is currently being performed.The device has been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.H10: d4 (expiry date: 02/2026).H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported that during a stent graft placement procedure in the subclavian vein, the distal end of the stent did not fully deploy and was stuck.It was further reported that a three millimeter balloon was used to inflate the distal tip of the stent to fully release the stent from the catheter and was successful.Furthermore, after post stent angiograms, the health care personnel noticed that there might be the radiopaque ring possibly may have been dislodged and migrated to the pulmonary artery.Reportedly, the health care personnel mentioned that the ring had embolized within the pulmonary artery.The current status of the patient is unknown.
 
Event Description
It was reported that during a stent graft placement procedure in the subclavian vein, the distal end of the stent did not fully deploy and was stuck.It was further reported that a three millimeter balloon was used to inflate the distal tip of the stent to fully release the stent from the catheter and was successful.Furthermore, after post stent angiograms, the health care personnel noticed that there might be the radiopaque ring possibly may have been dislodged and migrated to the pulmonary artery.Reportedly, the health care personnel mentioned that the ring had embolized within the pulmonary artery.The current status of the patient is unknown.
 
Manufacturer Narrative
Manufacturing review: based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.However, the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Investigation summary: the stent delivery system was returned for evaluation.The delivery mechanism was fully activated; the stent was completely deployed and missing, as it was placed in the patient.The distal part of the outer catheter including the radiopaque marker band was missing which leads to confirmed result for sheath break and detachment.Based on the provided information and the evaluation of the returned sample, the investigation is closed with confirmed results for break and detachment.A definite root cause for the reported event could not be determined.Labeling review: relevant labeling for this product was reviewed.The instruction for use states: "if unusual resistance or high deployment force is encountered during stent graft deployment, abort the procedure, remove the delivery system and use an alternative device." regarding preparation of the device the instruction for use states: "prior to loading the vascular system over a guide wire, both ports must be flushed with sterile saline (.).Flushing these lumens will also facilitate stent graft deployment".Regarding the anatomy of the placement site the instruction for use states: "prior to stent graft deployment (.), ensure that the proximal stent graft end is positioned in a straight section of the lumen to reduce the risk of increased deployment forces and possible failure to deploy".Regarding accessories the instruction for use states: "prepare a stiff 0.035" guidewire per its instructions for use and advance the guidewire under fluoroscopy to the target location.The use of an appropriately sized introducer sheath is recommended".The packaging pictograms indicate an introducer size of 10f and a 0.035" guidewire.With regards to stent placement, the instruction for use states "post dilate the stent graft with an angioplasty balloon sized appropriately as to ensure complete wall apposition to the reference vessel".The instruction for use also mentions detachment of device parts as a potential complication.D4 (expiry date: 02/2026).H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Manufacturer Narrative
H10: manufacturing review: the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.Investigation summary: the stent delivery system was returned for evaluation.The delivery mechanism was fully activated; the stent was completely deployed and missing, as it was placed in the patient.The distal part of the outer catheter including the radiopaque marker band was missing which leads to confirmed result for sheath break and detachment.Based on the provided information and the evaluation of the returned sample, the investigation is closed with confirmed results for break and detachment.A definite root cause for the reported event could not be determined.Labeling review: relevant labeling for this product was reviewed.The instructions for use states: "if unusual resistance or high deployment force is encountered during stent graft deployment, abort the procedure, remove the delivery system and use an alternative device." regarding preparation of the device the instructions for use states: "prior to loading the vascular system over a guide wire, both ports must be flushed with sterile saline.Flushing these lumens will also facilitate stent graft deployment".Regarding the anatomy of the placement site the instructions for use states: "prior to stent graft deployment, ensure that the proximal stent graft end is positioned in a straight section of the lumen to reduce the risk of increased deployment forces and possible failure to deploy".Regarding accessories the instructions for use states: "prepare a stiff 0.035" guidewire per its instructions for use and advance the guidewire under fluoroscopy to the target location.The use of an appropriately sized introducer sheath is recommended".The packaging pictograms indicate an introducer size of 10f and a 0.035" guidewire.With regards to stent placement, the instructions for use states "post dilate the stent graft with an angioplasty balloon sized appropriately as to ensure complete wall apposition to the reference vessel".The instructions for use also mentions detachment of device parts as a potential complication.H10: d4 (expiration date: 02/2026), g3.H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported that during a stent graft placement procedure in the subclavian vein for a thrombectomy procedure, the distal end of the stent allegedly did not fully deploy and became stuck in the catheter.It was further reported that a three millimeter balloon was used to inflate the distal tip of the stent to fully release the stent graft from the catheter and was successful.Furthermore, after post stent angiograms, the health care personnel noticed that there might be the radiopaque ring possibly may have been dislodged and migrated to the pulmonary artery.Reportedly, the health care personnel mentioned that the ring had embolized within the pulmonary artery.The patient is reportedly asymptomatic.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLUENCY PLUS ENDOVASCULAR STENT GRAFT
Type of Device
ENDOVASCULAR STENT GRAFT
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstr. 6
karlsruhe 76227
GM   76227
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key17796834
MDR Text Key324004196
Report Number2020394-2023-00719
Device Sequence Number1
Product Code PFV
UDI-Device Identifier04049519008707
UDI-Public(01)04049519008707
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P130029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 10/14/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberFEM14080
Device Lot NumberANHP2329
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/12/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/28/2023
Initial Date FDA Received09/22/2023
Supplement Dates Manufacturer Received09/26/2023
10/16/2023
Supplement Dates FDA Received09/28/2023
10/18/2023
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-